Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. (Q50999983)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 May 2013

Language	Label	Description	Also known as
English	Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.	scientific article published on 10 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

Hans-Peter Brunner-La Rocca

11

object named as

Hans-Peter Brunner-La Rocca

1 reference

Europe PubMed Central

26 March 2018

author name string

Sandra Sanders-van Wijk

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Stefano Muzzarelli

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Michael Neuhaus

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Stephanie Kiencke

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Micha Maeder

5

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Werner Estlinbaum

6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Daniel Tobler

7

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Kurt Mayer

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Paul Erne

9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Matthias E Pfisterer

10

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

TIME-CHF investigators

12

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

publication date

10 May 2013

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

European Journal of Heart Failure

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

15

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

910-918

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

Association between performance measures and clinical outcomes for patients hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Use of B-type natriuretic peptide outside of the emergency department

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

A review of heart failure management in the elderly population

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Drug treatment of chronic heart failure in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Frequency and predictors of hyperkalemia in patients ≥60 years of age with heart failure undergoing intense medical therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: results from the Italian Survey on Acute Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFT079

21 January 2018

Identifiers

10.1093/EURJHF/HFT079

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/23666681

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50999983&oldid=1517744781"